Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Can Immunopeptidomics Redefine Cancer Immunotherapy Development?
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
Immunopeptidomics analyzes antigenic peptides presented by MHC molecules, enhancing the development of targeted cancer immunotherapies.
2
This field aids in identifying novel T-cell targets and tumor-specific antigens, crucial for improving therapies for hard-to-treat cancers like PDAC.
3
High-resolution mass spectrometry (HRMS) is essential for identifying peptides bound to MHC molecules, facilitating comprehensive immunopeptidome coverage.
4
Innovations like tunable electron-activated dissociation (EAD) improve peptide fragmentation and differentiation of isomeric residues, impacting immune response.
5
Combining analytical approaches enhances specificity and throughput in immunopeptidomics, driving the design of personalized cancer immunotherapies.
